Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2013

Aug 8, 2013

30718_dirs_2013-08-08_18c6dd88-453e-4556-93d9-79d224b49e09.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-08-01

Reporting Person: Bazan J. Fernando (Chief Technical Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-08-01 Stock Option (Right to Buy) $76.02 A 10000 Acquired 2020-07-31 Common Stock (10000) Direct
2013-08-01 Stock Option (Right to Buy) $76.02 A 15000 Acquired 2020-07-31 Common Stock (15000) Direct

Footnotes

F1: Vests 3,333 on each of 8/1/14 and 8/1/15; 3,334 on 8/1/16.

F2: Vests 3,750 on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.